This site is part of the Global Exhibitions Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Informa

Pomella® Extract Helps Improve Cardio-Metabolic Health

Press Release

Researchers with the Srikot Research Institute studied the effects of Pomella® extract (from Verdure Sciences) in patients (20-60 years of age) with myocardial infarction in conjunction with regular prescribed medications. The study determined the effects of 300 mg/Pomella twice daily for 30 days on biomedical parameters like high-density lipoprotein (HDL), total cholesterol, triglycerides, low density lipoprotein (LDL), non-HDL cholesterol, serum homocysteine, high-sensitivity C-reactive protein (hs-CRP), and oxidized LDL (OX-LDL) as an add-on with regular medication showing improved antioxidant status of the blood biomarkers associated with cardiac health.

In this study, results of post treatment analysis showed a significant improvement in mean levels of total cholesterol, triglyceride, HDL, LDL, non-HDL cholesterol, serum homosystein, hs-CRP and OX-LDL after add-on treatment with Pomella compared to placebo. “The increase in HDL in combination with a decrease in LDL and other markers is quite impressive," stated Nikeeta Kheradia, research and development, Verdure Sciences®.

Furthermore, the same group of researchers studied the antioxidant effect of Pomella® extract as adjunct therapy at 300 mg twice daily for 30 days in comparison to placebo in 40 patients with diabetes mellitus type 2 and myocardial infarction. At the end of the study, results showed that the blood glucose levels and hemoglobin A1c (HbA1C) levels were significantly reduced compared to baseline.

Sonya Cropper, vice president of marketing & innovation with Verdure Sciences®, stated, “We are very excited to see the additional support of Pomella’s efficacious capabilities and potential health applications. It is impressive to see the impact Pomella has on biomarkers that influence health in these complementary clinical trials."

According to the American Heart Association, about 34 percent of adult Americans have metabolic syndrome, and in recent years, it has become much more common in the United States. They go on to explain that risk of developing metabolic syndrome increases with age and that prevalence of the syndrome is also increasing globally. As metabolic syndrome is usually associated with a greater risk of cardiac impairment and diabetes, daily supplementation with Pomella extract could help maintain glucose homeostasis, promote heart health, and promote glycemic health.

Kristen Marshall, marketing coordinator with Verdure Sciences®, went on to say, “It is exciting to see the synergies in these adjunctive opportunities. Communication between patients and healthcare providers is imperative and this study helps to confirm the need for both patients and physicians to be open and converse about their supplement regimens."

For more information, visit pomextract.com, vs-corp.com or booth AA165 at Supply Side West.

comments powered by Disqus